You need to sign in or sign up before continuing.
The Journal of pediatrics
-
The Journal of pediatrics · Nov 2006
Randomized Controlled Trial Multicenter StudySafety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
The safety of a booster dose of a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with five doses of acellular pertussis-containing vaccine. ⋯ These results suggest that Tdap is well tolerated as a sixth consecutive dose of acellular pertussis-containing vaccine.